Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Labored Breathing

Staff  |  Issue: January 2007  |  January 1, 2007

Although bronchoalveolar lavage remains a valuable research tool, it may be less useful in the clinic. For technical reasons, the interpretation of bronchoalveolar lavage fluid can be difficult when performed in community-based laboratories. Another disadvantage of this test is the potential for sampling error because generally only one or two sites are lavaged. When performed in a standardized fashion in specialized laboratories, however, it does provide clues to the presence of active ILD.

Table 2: Baseline Evaluation of the SSc Patients with Dyspena.
click for large version

Lung Biopsy

Open lung biopsy is rarely indicated unless there is clinical concern for other pulmonary conditions that might confound SSc (e.g., bronchiolitis obliterans with organizing pneumonia, sarcoidosis, or aspiration, among others). The predominant histologic pattern of SSc-ILD is a nonspecific interstitial pneumonitis. CT findings in SSc closely resemble those observed in patients with idiopathic nonspecific interstitial pneumonitis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Echocardiography

Obtain echocardiogram with Doppler at baseline on all newly diagnosed patients, and perform serial studies at intervals, depending upon the patient’s clinical symptoms and the results of their other tests (e.g., DLCO). Echocardiography is an important tool to evaluate the complaint of dyspnea, particularly when PAH is suspected (e.g., in the patient found to have a low DLCO percent predicted with normal or only slightly reduced FVC percent predicted [vide supra]).

In two recent studies conducted in community-based rheumatology practices, the prevalence of PAH as defined by an estimated RV systolic pressure of >40 mm Hg was found to be approximately 25% in SSc and mixed connective tissue disease patients.8,9 Thus, one must have a high index of suspicion for PAH in this patient population.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Echocardiography provides important information about right atrial (RA) and right ventricular (RV) size and function—especially RV systolic pressure. (See Figure 3, page 18.) Congenital heart disease, valvular disease, pericardial effusion, and left-sided heart dysfunction may also be detected.

Figure 1: Summary of disease sequelae in CIDs.
Figure 1: Six-Minute Walk Test. Perform this submaximal exercise test as part of the baseline assessment of dyspnea in the SSc patient and monitor serially to assess progression or response to treatment. A forehead oximeter detects exercise-induced hypoxemia.

Right Heart Catheterization

Because the Doppler echocardiogram may overestimate or underestimate RV systolic pressure, right heart catheterization is required whenever PAH is suspected. Right heart catheterization remains the gold standard for accurate diagnosis of PAH and also permits assessment of concomitant left ventricular disease by measuring pulmonary capillary wedge pressure or left ventricular end-diastolic pressure. PAH is defined as a mean pulmonary artery pressure of >25 mm Hg at rest, or >30 mm Hg with exercise, and a normal pulmonary capillary wedge pressure (<15 mm Hg). Diastolic dysfunction is not an uncommon cause for dyspnea in SSc patients. Treatment of diastolic dysfunction differs significantly from that of PAH; therefore, cardiac catheterization is critical for accurate diagnosis and management of the SSc patient with suspected pulmonary vascular disease.

Diagnosis and Management

My recommended baseline cardiopulmonary evaluation for a newly diagnosed SSc patient is shown in Table 2. (See above right.) If baseline studies are normal and the patient has no complaints of dyspnea, I recommend annual re-assessment (sooner if the patient develops symptoms). If PFTs are abnormal, further work-up is necessary and should be guided by the particular pattern of PFT abnormalities. For example, a restrictive PFT pattern suggests SSc-ILD, which should be confirmed by CT.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsSystemic Sclerosis Tagged with:DiagnosisInterstitial Lung DiseaseManagementpulmonary arterial hypertensionSclerodermaSystemic sclerosisTreatment

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Progress Continues in Systemic Sclerosis

    March 1, 2010

    Advances in genetics and potential therapies shed new light on the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences